PubRank

S A Fiscus

Author PubWeight™ 84.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997 6.34
2 Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000 4.91
3 Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001 4.76
4 Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999 4.16
5 High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998 3.46
6 Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997 3.42
7 Sexual transmission of HIV: infectiousness and prevention. AIDS 1999 2.59
8 Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997 2.51
9 Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 1996 2.12
10 HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001 2.08
11 Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol 1997 2.04
12 Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J Clin Microbiol 1994 1.85
13 The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999 1.76
14 Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 2000 1.60
15 Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 1998 1.59
16 Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest 1975 1.57
17 Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998 1.42
18 Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994 1.38
19 Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000 1.38
20 Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1999 1.32
21 Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. J Infect Dis 1999 1.32
22 HIV-1 viral load in blood, semen and saliva. AIDS 1997 1.27
23 Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol 1987 1.25
24 Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med 2001 1.18
25 Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses 2005 1.14
26 The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850). J Infect Dis 2000 1.11
27 Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. J Infect Dis 2001 1.06
28 Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J Infect Dis 1993 1.06
29 Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis 1998 1.04
30 Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359. J Infect Dis 2000 1.01
31 Two phases of HIV RNA decay in CSF during initial days of multidrug therapy. Neurology 2003 1.00
32 Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 0.98
33 Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides. J Clin Microbiol 1985 0.95
34 Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol 2001 0.93
35 Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J Virol Methods 1996 0.93
36 Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.91
37 Inhibition of HIV-1 by modification of a host membrane protease. Int Immunol 1995 0.89
38 Limits on oral transmission of HIV-1. Lancet 2000 0.89
39 Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res 2001 0.89
40 Rational testing of the HIV-exposed infant. Pediatrics 2001 0.88
41 Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res 1995 0.88
42 Plasma HIV burden in Malawian children co-infected with rotavirus. AIDS 2001 0.86
43 Macrophages in efferent lymph of sheep and their role in lectin-induced lymphocyte blastogenesis. Int Arch Allergy Appl Immunol 1983 0.84
44 Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil. J Infect Dis 1999 0.84
45 Shedding of HIV-1 in semen during primary infection. AIDS 1997 0.84
46 Functional differences in the peplomer glycoproteins of feline coronavirus isolates. J Virol 1987 0.82
47 Epitope-specific antibody responses to virulent and avirulent feline infectious peritonitis virus isolates. J Clin Microbiol 1987 0.82
48 Mitogen-induced blastogenesis of peripheral blood and efferent lymph lymphocytes from sheep. Am J Vet Res 1982 0.79
49 Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). J Clin Microbiol 1994 0.79
50 Functional and structural alterations of the nervous system induced by avian retrovirus RAV-7. Microb Pathog 1988 0.77
51 Short courses of zidovudine and perinatal transmission of HIV. N Engl J Med 1999 0.77
52 Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. J Clin Microbiol 1996 0.77
53 Variation in mitogen-induced ovine lymphocyte blastogenesis: adherent cells or 2-mercaptoethanol restore randomly depressed responses. Vet Immunol Immunopathol 1982 0.76
54 Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid. J Clin Microbiol 2001 0.76
55 Early detection of HIV in neonates. N Engl J Med 1993 0.75
56 Immune activation and plasma viral load in HIV-infected African individuals. AIDS 1999 0.75
57 Rapid enzyme-linked immunosorbent assay for detecting antibodies to canine parvovirus. Am J Vet Res 1985 0.75
58 Chromium-51-release assay of antibody and complement-mediated cytotoxicity for contagious ecthyma virus-infected cells. Am J Vet Res 1978 0.75